Results 21 to 30 of about 24,186,788 (290)

High Frequency of Non-B Subtypes in Newly Diagnosed HIV-1 Infections in Switzerland

Journal of Acquired Immune Deficiency Syndromes, 1999
HIV-1 subtypes were determined in newly diagnosed residents of Switzerland. Blood was anonymously collected from patients with a first confirmed positive HIV-1 test result. Viral DNA from the env V3-V5 region was amplified by nested polymerase chain reaction (PCR) and screened for subtype B by heteroduplex mobility assay.
Böni, J, Pyra, H, Gebhardt, M, Perrin, L, Bürgisser, P, Matter, L, Fierz, W, Erb, P, Piffaretti, J C, Minder, E, Grob, P, Burckhardt, J J, Zwahlen, M, Schüpbach, J   +13 more
openaire   +4 more sources

HIV-1 non-B subtypes in Italy: a growing trend.

The new microbiologica, 2012
Sequence analysis plays an important role in the management of patients chronically infected with HIV-1. Knowledge of the viral genotype and drug resistance mutations is crucial for the correct management of these patients. From this point of view, the experience of researchers in the HIV-1 field and the introduction of the HIV-1 genotyping resistance ...
Ciccozzi, M, SANTORO, MARIA, Giovanetti, M, Andrissi, L, BERTOLI, ADA, Ciotti, M.   +5 more
core   +4 more sources

Metabolically Unhealthy Obesity: Novel Subtypes Defined by Integrated Metabolomics and Hematology [PDF]

Biomedicines
Objectives: The aim was to identify metabolic subtypes within metabolically unhealthy obesity (MUO) using integrated metabolomics and hematology data and evaluate their differential risks for cardiovascular–kidney–metabolic (CKM)-related outcomes ...
Xuan Huang, Yuhong Liu, Xiaoqian Zhu, Zhennan Lin, Yansong Guo, Kaiyang Lin   +5 more
doaj   +2 more sources

Specific non-B subtypes sread and response to HAARTt compared to B subtype with baseline wild-type genotype

, 2010
We evaluated non-B subtypes prevalence,temporal trends and associated epidemiological factors and response to ...
M. Violin, G. Casazza, G. Meini, A. P. Callegaro, P. Corsi, F. Maggiolo, E. Boeri, G. Campanili, N. Giannotti, FRANCISCI, Daniela, A. Orani, M. Zazzi, C. Balotta   +12 more
openaire   +2 more sources

Are non-B subtypes less susceptible to antiretroviral drugs? A bioinformatical approach to prediction of non-B subtype susceptibility [PDF]

Journal of the International AIDS Society, 2008
Address: 1University of Copenhagen, Copenhagen, Denmark, 2Department of Infection & Population Health, Royal Free Campus, University College London, London, UK, 3Department of Infection & Population Health, Royal Free Campus, University College London/University of Copenhagen, London, UK and 4University of Copenhagen/4 Centre for Viral Diseases/KMA ...
Kjær, J, Høj, L, Cozzi-Lepri, A, Fox, Z, Lundgren, JD   +4 more
openaire   +1 more source

Increasing Frequency and Transmission of HIV-1 Non-B Subtypes among Men Who Have Sex with Men in the Swiss HIV Cohort Study [PDF]

, 2021
BACKGROUND In Switzerland, HIV-1 transmission among men who have sex with men (MSM) has been dominated by subtype B, whilst non-B subtypes are commonly attributed to infections acquired abroad among heterosexuals.
Yerly, Sabine, Günthard, Huldrych F, Stöckle, M., Nguyen, Huyen, Huber, M., Perreau, M., Chaudron, Sandra E, Stöckle, Marcel, Hirsch, H.H., Hirsch, Hans H, Ballouz, T., Chaudron, S.E., Cavassini, M., Vernazza, P., Ballouz, Tala, Bernasconi, Enos, Chaudron, Sandra Elisabeth, Swiss HIV Cohort Study, Nguyen, H., Kouyos, Roger D, Duran Ramirez, J.J., Furrer, Hansjakob, Kusejko, K., Ramette, A., Furrer, H., Ramette, Alban; https://orcid.org/, Kouyos, R.D., Kouyos, Roger D; https://orcid.org/, Günthard, H.F., Cavassini, Matthias; https://orcid.org/, Ramette, Alban, Kusejko, Katharina, Yerly, S., Perreau, Matthieu, Vernazza, Pietro, Duran Ramirez, Jessy J, Yerly Ferrillo, Sabine, Huber, Michael, Cavassini, Matthias, Bernasconi, E., H Furrer, L Kaiser, M Cavassini, B Martinez de Tejada, E Bernasconi, Marcel Stöckle, H Kovari, J Fehr, G Martinetti, L Elzi, M Battegay, A Ciuffi, Huyen Nguyen, Roger D Kouyos, M Stöckle, G Pantaleo, G Dollenmaier, T Klimkait, H C Bucher, P Tarr, null null, C Marzolini, C R Kahlert, Enos Bernasconi, P Schmid, K Kusejko, D Haerry, D Nicca, K J Metzner, M Egger, Katharina Kusejko, C A Fux, Tala Ballouz, H F Günthard, G Wandeler, P Vernazza, I Hösli, R Speck, D L Braun, R D Kouyos, A Rauch, S Yerly, K Aebi-Popp, H H Hirsch, M Huber, Hansjakob Furrer, Matthieu Perreau, Sandra E Chaudron, Alban Ramette, J Fellay, C Rudin, R Weber, O Keiser, M Hoffmann, Jessy J Duran Ramirez, B Ledergerber, Hans H Hirsch, Michael Huber, Pietro Vernazza, M Perreau, N Müller, A Calmy, Sabine Yerly, J Böni, A Anagnostopoulos, P Paioni, B Hasse, A Trkola, Huldrych F Günthard, Matthias Cavassini   +109 more
core   +2 more sources

Characteristics of HIV‐1 non‐B subtype infections in Northwest Poland [PDF]

Journal of Medical Virology, 2010
AbstractThe number of non‐B subtype HIV‐1 infections in Europe has been increasing even though major regional differences have been observed. This trend was investigated in northwestern Poland using sequence and epidemiological data from a cohort of 102 HIV‐1‐infected patients from Szczecin, Poland.
Parczewski, Milosz, Leszczyszyn-Pynka, Magdalena, Bander, Dorota, Urbańska, Anna, Stańczak, Grzegorz, Boroń-Kaczmarska, Anna   +5 more
openaire   +2 more sources

Parkinson Disease Subtype Stability and Eventual Convergence. [PDF]

Ann Clin Transl Neurol
ABSTRACT Objective Previous research identified distinct Parkinson disease (PD) clinical subtypes of “Motor Only,” “Psychiatric & Motor,” and “Cognitive & Motor” based on comprehensive, multidomain classification. Whether these subtypes reflect distinct trajectories or progressive disease stages remains unknown.
Rosok LM, Lessov-Schlaggar CN, Eid AM, Foster ER, Maiti B, Domash H, Hwang H, Perrin RJ, Kotzbauer PT, Perlmutter JS, Campbell MC.   +10 more
europepmc   +2 more sources

Raltegravir clinical efficacy against B subtype and non-B subtype HIV-1 is similar [PDF]

Journal of the International AIDS Society, 2008
Methods Each study was double-blind and randomized; all pts received a background ART regimen (see table in Figure 1). Primary results have been presented for each study. Protocol (P) 004 in treatment-naive pts was a dose-ranging study of RAL vs. efavirenz (EFV) until week 48 after which all pts in RAL groups received 400 mg BID. BENCHMRK-1 and -2 were
Teppler, H, Rockstroh, J, Isaacs, R, Wan, H, Hervey, C, Miller, M, Nguyen, BY   +6 more
openaire   +1 more source

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy [PDF]

, 2012
We analysed the 12-week virological response to protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI) therapy in 1108 patients carrying B or non-B human immunodeficiency virus (HIV)-1 subtypes with matched resistance mutation ...
Casazza, G., Balotta, C., P. Corsi, FRANCISCI, Daniela, N. Giannotti, G. Meini, Meini, G., Gianotti, N., D. Francisci, Maggiolo, F., M. Franzetti, N. Gianotti, T. Carli, Zazzi, M., F. Maggiolo, Carli, T., Violin, M., Filice, G., M. Violin, C. Balotta, G. Filice, Franzetti, M., Callegaro, A., R. Rossotti, A. Callegaro, Corsi, P., G. Casazza, Francisci, D., Rossotti, R., Pignataro, A.R., Paolucci, S., . Rossotti, S. Paolucci, M. Zazzi, A. R. Pignataro, A.R. Pignataro   +35 more
core   +2 more sources